** Shares of derivatives exchange operator CME Group CME.O rise as much as 4.9%, last up 3.9% at $251.05
** CME reports Q4 adjusted profit of $2.52/shr, beating Wall Street expectations of $2.44/shr, according to estimates compiled by LSEG
** Uncertainty around the U.S. election and economy, as well as geopolitics in the reported quarter, drove up demand for CME's hedging products
** "With volume growth across every asset class, we hit new records in interest rates, including U.S. Treasury and SOFR complexes, as well as in agricultural, foreign exchange and metals markets," CEO Terry Duffy says
** Q4 clearing and transaction fees, CME's major chunk of revenue, rose 4% to $1.23 billion
** Raymond James says better pricing in interest rate and equity index futures drove the Q4 beat
** CME stock rose 10.3% in 2024
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。